MiniMed Group, Inc. Common Stock (MMED) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
MiniMed Group, Inc. Common Stock stock (MMED) is currently trading at $16.57. MiniMed Group, Inc. Common Stock PS ratio (Price-to-Sales) is 1.67. WallStSmart rates MMED as Sell.
- MMED PE ratio analysis and historical PE chart
- MMED PS ratio (Price-to-Sales) history and trend
- MMED intrinsic value — DCF, Graham Number, EPV models
- MMED stock price prediction 2025 2026 2027 2028 2029 2030
- MMED fair value vs current price
- MMED insider transactions and insider buying
- Is MMED undervalued or overvalued?
- MiniMed Group, Inc. Common Stock financial analysis — revenue, earnings, cash flow
- MMED Piotroski F-Score and Altman Z-Score
- MMED analyst price target and Smart Rating
MiniMed Group, Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
MiniMed Group, Inc. Common Stock (MMED) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around operating margin and profit margin. Significant fundamental concerns warrant caution or avoidance.
MiniMed Group, Inc. Common Stock (MMED) Key Strengths (3)
Paying $1.67 for every $1 of annual revenue
Trading at 1.28x book value, attractively priced
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
MiniMed Group, Inc. Common Stock (MMED) Areas to Watch (4)
Company is losing money with a negative profit margin
Near-zero operating margins, business under pressure
Very low institutional interest at 0.00%
Solid revenue growth at 13.10% per year
MiniMed Group, Inc. Common Stock (MMED) Detailed Analysis Report
Overall Assessment
This company scores 34/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 3 register as strengths (avg 7.7/10) while 4 fall into concern territory (avg 2.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Market Cap. Valuation metrics including Price/Sales (1.67), Price/Book (1.28) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Profit Margin, Operating Margin, Institutional Own.. Growth concerns include Revenue Growth at 13.10%, which may limit upside. Profitability pressure is visible in Operating Margin at 1.36%, Profit Margin at -7.31%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Profit Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at 1.36% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 13.10% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Profit Margin and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
Compare MMED with Competitors
Top HEALTH INFORMATION SERVICES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for MiniMed Group, Inc. Common Stock (MMED) · HEALTHCARE › HEALTH INFORMATION SERVICES
The Big Picture
MiniMed Group, Inc. Common Stock is in a turnaround phase, with management focused on restoring profitability. Revenue reached 2.9B with 13% growth year-over-year. The company is currently unprofitable, posting a -7.3% profit margin.
Key Findings
Spending 15% of revenue (438M) on R&D, reinforcing its commitment to innovation and future growth.
The company is unprofitable with a -7.3% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -53M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact MiniMed Group, Inc. Common Stock.
Bottom Line
MiniMed Group, Inc. Common Stock is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 1:05:44 PM
About MiniMed Group, Inc. Common Stock(MMED)
NASDAQ
HEALTHCARE
HEALTH INFORMATION SERVICES
USA
Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.